Trium Capital’s Theratechnologies THTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-318,830
Closed -$1.08M 66
2025
Q3
$1.08M Buy
+318,830
New +$1.02M 0.42% 27

Trium Capital's THTX Position: Q4 2025 in Review

Trium Capital sold out of Theratechnologies (THTX) in Q4 2025, closing a stake of 318,830 shares — an estimated $1.08M sold.

Trium Capital first reported a position in THTX in Q3 2025 and held it in 1 quarter. The position peaked at $1.08M in Q3 2025. 0 funds tracked by Wall St. Rank hold THTX as of Q4 2025.

  • Trium Capital reported no remaining Theratechnologies position as of Q4 2025 after selling out during the quarter.
  • Trium Capital sold 318,830 Theratechnologies shares in Q4 2025, an estimated $1.08M.
  • Trium Capital first reported a position in Theratechnologies in Q3 2025 and held it in 1 quarter.
  • Trium Capital's Theratechnologies position peaked at $1.08M in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Theratechnologies as of Q4 2025.

Based on Trium Capital's 13F filing for Q4 2025, filed 22 Jan 2026.